Telsey Advisory Group reaffirmed their market perform rating on shares of Under Armour (NYSE:UAA – Free Report) in a report released on Friday morning,Benzinga reports. They currently have a $10.00 price objective on the stock.
A number of other research firms also recently issued reports on UAA. Argus raised Under Armour to a “strong-buy” rating in a research report on Thursday, August 15th. Truist Financial lifted their price objective on Under Armour from $8.00 to $11.00 and gave the stock a “hold” rating in a report on Friday, November 8th. Needham & Company LLC reaffirmed a “hold” rating on shares of Under Armour in a report on Friday. UBS Group lifted their target price on shares of Under Armour from $12.00 to $16.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Finally, Robert W. Baird upped their price target on shares of Under Armour from $8.00 to $10.00 and gave the company a “neutral” rating in a research note on Friday, November 8th. Three equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Under Armour presently has an average rating of “Hold” and an average target price of $9.34.
Check Out Our Latest Research Report on Under Armour
Under Armour Trading Down 8.1 %
Insiders Place Their Bets
In related news, CFO David Bergman sold 30,000 shares of the company’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $9.09, for a total value of $272,700.00. Following the completion of the transaction, the chief financial officer now directly owns 494,210 shares in the company, valued at approximately $4,492,368.90. The trade was a 5.72 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Mehri Shadman sold 17,240 shares of the firm’s stock in a transaction dated Friday, November 15th. The shares were sold at an average price of $8.76, for a total value of $151,022.40. Following the sale, the insider now owns 182,538 shares in the company, valued at $1,599,032.88. The trade was a 8.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 56,879 shares of company stock worth $508,642 in the last ninety days. 15.60% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Under Armour
Hedge funds and other institutional investors have recently modified their holdings of the company. Nomura Asset Management Co. Ltd. raised its holdings in shares of Under Armour by 163.6% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 2,900 shares of the company’s stock valued at $26,000 after buying an additional 1,800 shares in the last quarter. Allspring Global Investments Holdings LLC purchased a new position in shares of Under Armour during the third quarter worth approximately $56,000. Optas LLC purchased a new position in shares of Under Armour during the second quarter worth approximately $72,000. CWM LLC lifted its holdings in shares of Under Armour by 20.7% in the 3rd quarter. CWM LLC now owns 8,211 shares of the company’s stock worth $73,000 after acquiring an additional 1,409 shares during the last quarter. Finally, Koss Olinger Consulting LLC purchased a new stake in shares of Under Armour in the 2nd quarter valued at $79,000. 34.58% of the stock is currently owned by hedge funds and other institutional investors.
Under Armour Company Profile
Under Armour, Inc, together with its subsidiaries, engages developing, marketing, and distributing performance apparel, footwear, and accessories for men, women, and youth. The company provides its apparel in compression, fitted, and loose fit types. It also offers footwear products for running, training, basketball, cleated sports, recovery, and outdoor applications.
See Also
- Five stocks we like better than Under Armour
- Roth IRA Calculator: Calculate Your Potential Returns
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What Investors Need to Know About Upcoming IPOs
- GRAIL: Biotech Stock Targeting $100B Cancer Market
- Stock Splits, Do They Really Impact Investors?
- MarketBeat Week in Review – 12/9 – 12/13
Receive News & Ratings for Under Armour Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Under Armour and related companies with MarketBeat.com's FREE daily email newsletter.